Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 306.00 TWD
Change Today -2.00 / -0.65%
Volume 172.0K
4174 On Other Exchanges
Symbol
Exchange
Taiwan
As of 9:49 PM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

obi pharma inc (4174) Snapshot

Open
309.00
Previous Close
308.00
Day High
310.50
Day Low
305.00
52 Week High
10/17/14 - 455.00
52 Week Low
06/4/15 - 282.00
Market Cap
52.2B
Average Volume 10 Days
411.9K
EPS TTM
-4.46
Shares Outstanding
170.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for OBI PHARMA INC (4174)

Related News

No related news articles were found.

obi pharma inc (4174) Related Businessweek News

No Related Businessweek News Found

obi pharma inc (4174) Details

OBI Pharma, Inc. engages in the research and development of medicines. It offers OBI-888, an anti-globo H monoclonal antibody that could complement the active immunotherapy of cancer, principally for the patients undergoing radiation and/or chemo therapies. The company serves patients in hospitals and cancer treatment centers. It assists aesthetics clinics and medical markets through a network of distributors and dealers in Taiwan, China, Hong Kong, and the United States. The company was founded in 2002 and is based in Taipei, Taiwan. OBI Pharma, Inc. is a subsidiary of Optimer Pharmaceuticals.

Founded in 2002

obi pharma inc (4174) Top Compensated Officers

Vice-Chairman and Chief Planner of Global Cli...
Total Annual Compensation: 4.4M
Compensation as of Fiscal Year 2013.

obi pharma inc (4174) Key Developments

OBI Pharma, Inc., Annual General Meeting, Jun 03, 2015

OBI Pharma, Inc., Annual General Meeting, Jun 03, 2015.

OBI Pharma, Inc., Special/Extraordinary Shareholders Meeting, Jul 23, 2014

OBI Pharma, Inc., Special/Extraordinary Shareholders Meeting, Jul 23, 2014.

OBI Pharma, Inc., Annual General Meeting, Jul 23, 2014

OBI Pharma, Inc., Annual General Meeting, Jul 23, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4174:TT 306.00 TWD -2.00

4174 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4174.
View Industry Companies
 

Industry Analysis

4174

Industry Average

Valuation 4174 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 6.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OBI PHARMA INC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.